Logo
Q

Quell Therapeutics

162 employees

An exciting new cell therapy immunology biotech committed to transforming patient's lives in solid organ transplantation and auto-immune conditions. Our company is growing and we are exciting about the future! Our vision is to become a world leader in new cell therapy and the people are at the heart of what we do. We treat our people with respect, working collaboratively across the business, taking ownership and accountability for the outcomes and results we delivery. Most of all we work with integrity to innovate and bring the best version of ourselves to the job every day.

Investor insights

Funding rounds participated in

$156M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2019

Funding rounds raised

Total raised

$156M

from 3 investors over 1 rounds

Q

Quell Therapeutics raised $156M on December 29, 2021

Investors: SV Health Investors, Fidelity and + 8 Other investors

FAQ